Alvaro
Lassaletta Atienza
Consultor Médico
University of Minnesota
Mineápolis, Estados UnidosUniversity of Minnesota-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2016
-
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma
Pediatric Blood and Cancer, Vol. 63, Núm. 10, pp. 1761-1770